Study of Salirasib to Treat Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Carcinoma, Non-Small-Cell Lung
- First Posted Date
- 2007-09-18
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- Concordia Pharmaceuticals, Inc
- Target Recruit Count
- 71
- Registration Number
- NCT00531401
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath